GlassScriptPhysician profile
Jaclyn N Springer
NPI 1720748825
$14,995.60
in general payments reported to CMS, 2019-2025
39 companies · $6,151 in 2025
The $6,151 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $3,035 · 2023: $1,967 · 2024: $3,843 · 2025: $6,151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,954 · Travel and Lodging: $2,007 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,953.76 |
| Travel and Lodging | $2,007.08 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,976.71 | 2022-2025 | Watchman, Watchman Flx, Watchman Access System |
| Abbvie INC. | $1,409.57 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $737.17 | 2022-2025 | Farxiga, Airsupra, Tezspire |
| Lilly USA, LLC | $657.06 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $590.25 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| E.R. Squibb & Sons, L.L.C. | $561.22 | 2022-2024 | Opdivo, Camzyos, Eliquis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $429.56 | 2022-2025 | Xifaxan, Trulance |
| Exact Sciences Corporation | $405.56 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Pfizer INC. | $382.04 | 2022-2025 | |
| Amgen INC. | $286.43 | 2022-2025 | Tezspire, Repatha, Otezla |
| Alexion Pharmaceuticals, INC. | $256.99 | 2023-2024 | Ultomiris, Soliris |
| Janssen Pharmaceuticals, INC | $195.23 | 2022-2024 | Xarelto |
| Glaxosmithkline, LLC. | $179.79 | 2022-2025 | Trelegy Ellipta, Arexvy |
| Sanofi-Aventis U.S. LLC | $161.65 | 2022-2025 | |
| Inari Medical, INC. | $159.78 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $143.11 | 2023-2025 | Rexulti |
| Merck Sharp & Dohme LLC | $143.04 | 2022-2025 | Verquvo, Gardasil 9, Capvaxive |
| Phathom Pharmaceuticals, INC. | $138.68 | 2025 | Voquezna |
| Lundbeck LLC | $124.52 | 2023-2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $112.25 | 2022-2025 | Jardiance |
| Eisai INC. | $110.93 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $105.16 | 2022-2025 | |
| Verona Pharma, INC. | $83.33 | 2025 | Ohtuvayre |
| Astellas Pharma US INC | $69.04 | 2023-2024 | Veozah |
| Biohaven Pharmaceutical Holding Company LTD. | $68.96 | 2022 | |
| Aimmune Therapeutics, INC. | $68.13 | 2024-2025 | Zenpep |
| Stryker Corporation | $58.07 | 2025 | Flowtriever, Clottriever Bold Catheter |
| Nestle Healthcare Nutrition INC. | $55.30 | 2023 | |
| Daiichi Sankyo INC. | $51.85 | 2023 | Injectafer |
| Tactile Systems Technology INC | $47.67 | 2024 | Flexitouch Plus, Entre Plus |
| Abiomed | $42.39 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $36.39 | 2025 | Caplyta |
| Novartis Pharmaceuticals Corporation | $32.70 | 2022-2023 | |
| Dexcom, INC. | $30.61 | 2023 | Dexcom G6 Transmitter |
| Shield Therapeutics INC | $20.13 | 2023 | Accrufer |
| Xeris Pharmaceuticals, INC. | $19.26 | 2023 | Gvoke Hypopen |
| Axsome Therapeutics, INC. | $18.94 | 2025 | Auvelity |
| Amarin Pharma, INC. | $13.21 | 2022 | |
| Sanofi Pasteur INC. | $12.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaclyn Springer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.